Compared to ENTA’s previous slide set (from the Leerink webcast—see #msg-128740228), slide #16 in the current slide set, which pertains to the design of FXR agonists, is new.
(Three slides from the old slide set pertaining to rat data have been removed, so there are two fewer slides, all told, in the current slide set.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”